Optometrist · Fresno, CA
NPI
1386738367
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7075 N Sharon Ave
Fresno, CA, 93720
Phone (559) 486-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
1,492 services
Medicare patients, 2024
854
Average age 76
Drug cost, 2024
$445K
1,204 prescriptions
Company payments, 2025
$794
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John G Barron was code 92014 (ophthalmological e&m), 633 times for 623 patients. In total John G Barron billed 1,492 services in 20 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 633 | 623 | $85.37 | $54K |
| 99213 Office E&M - Established | Office | 270 | 213 | $64.28 | $17K |
| 92133 Computerized Ophthalmic Imaging | Office | 163 | 135 | $24.45 | $3,986 |
| 92083 Vision, Hearing, and Speech Services | Office | 159 | 131 | $45.41 | $7,220 |
| 92134 Computerized Ophthalmic Imaging | Office | 111 | 93 | $29.84 | $3,312 |
| 92004 Ophthalmological E&M | Office | 68 | 68 | $105.41 | $7,168 |
| 76514 Ultrasound - Nonspecific | Office | 20 | 20 | $8.28 | $166 |
| 92020 Ophthalmological E&M | Office | 18 | 18 | $16.93 | $305 |
| 99212 Office E&M - Established | Office | 12 | 12 | $35.01 | $420 |
By year: 2022 $96K for 1,422 services; 2023 $108K for 1,487 services; 2024 $96K for 1,492 services.
Medicare prescription drug claims, 2024
In 2024, the drug John G Barron prescribed most often to Medicare patients was Latanoprost, with 211 prescriptions and refills. In total John G Barron wrote 1,204 Medicare prescriptions that cost $445K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 211 | 327 | 62 | $1,923 |
| Azelastine Hcl Generic | 175 | 233 | 69 | $4,459 |
| Cyclosporine Generic | 131 | 275 | 52 | $58K |
| Restasis Cyclosporine | 130 | 264 | 60 | $157K |
| Xiidra Lifitegrast | 83 | 126 | 34 | $82K |
| Timolol Maleate Generic | 73 | 108 | 18 | $606 |
| Brimonidine Tartrate Generic | 56 | 78 | 13 | $300 |
| Xdemvy Lotilaner | 39 | 60 | 37 | $70K |
| Lumigan Bimatoprost | 33 | 48 | Under 11 | $11K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 31 | 31 | 31 | $307 |
| Prednisolone Acetate Generic | 30 | 34 | 25 | $1,113 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 25 | 53 | 12 | $331 |
| Tyrvaya Varenicline Tartrate | 20 | 20 | Under 11 | $12K |
| Erythromycin Erythromycin Base | 20 | 20 | 15 | $178 |
| Restasis Multidose Cyclosporine | 13 | 16 | Under 11 | $9,408 |
Brand drugs: 636 claims; generic drugs: 568 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John G Barron $794 ($794 in general payments such as food, travel and fees) from 11 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $253.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 9 | $253 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $125 |
| Alcon Vision LLC ALC | 4 | $88.03 |
| Dompe US, Inc. | 3 | $79.48 |
| Johnson & Johnson Vision Care, Inc. JNJ | 1 | $58.29 |
| Glaukos Corporation GKOS | 1 | $45.93 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $38.73 |
| Abbvie Inc. ABBV | 1 | $34.93 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $28.61 |
| Oyster Point Pharma, Inc. | 1 | $26.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.